The hepatitis B virus X protein (HBx) is a broadly acting transactivat
or implicated in the development of liver cancer. Recently, HBx has be
en reported to interact with several different cellular proteins, incl
uding our report of its binding to XAP-1, the human homolog of the sim
ian repair protein UVDDB. In the present study, several HBx mutants we
re used to localize the minimal domain of HBx required for binding to
XAP-1/UVDDB to amino acids 55 to 101. The normal function of XAP-1/UVD
DB is thought to involve binding to damaged DNA, the first step in nuc
leotide excision repair (NER); therefore, we hypothesized that this in
teraction may affect the cell's capacity to correct lesions in the gen
ome. When tested in two independent assays that measure NER (unschedul
ed DNA synthesis and host cell reactivation), the expression of HBx si
gnificantly inhibited the ability of cells to repair damaged DNA. Unde
r the assay conditions, HBx was expressed at a level similar to that p
reviously observed during natural viral infection and was able to tran
sactivate several target reporter genes. These results are consistent,
vith a model in which HBx acts as a cofactor in hepatocarcinogenesis b
y preventing the cell from efficiently repairing damaged DNA, thus lea
ding to an accumulation of DNA mutations and, eventually, cancer. An a
dverse effect on cellular DNA repair processes suggests a new mechanis
m by which a tumor-associated virus might contribute to carcinogenesis
.